Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “United Kingdom”

A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDACActive Not Recruiting
NCT05968326Phase 2Updated Sep 9, 2026
Sponsor: Genentech, Inc.
Adenocarcinoma, Pancreatic Ductal
United States, Belgium, Canada, France, Germany +5 more
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)Recruiting
NCT07133633Phase 2Updated Sep 9, 2026
Sponsor: Merck Sharp & Dohme LLC
Radiographic Axial Spondyloarthritis
United States, Brazil, Canada, Chile, China +9 more
A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung CancerActive Not Recruiting
NCT05091567Phase 3Updated Sep 9, 2026
Sponsor: Hoffmann-La Roche
Small-Cell Lung Cancer
United States, Belgium, Germany, Greece, Hungary +8 more
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia ARecruiting
NCT07416526Phase 3Updated Sep 9, 2026
Sponsor: Hoffmann-La Roche
Hemophilia A
United States, Argentina, Brazil, Denmark, France +10 more
PNS Motor Stimulation StudyCompleted
NCT07810712NAUpdated Sep 9, 2026
Sponsor: Walton Centre NHS Foundation Trust
Stroke · Paralysis Arm · Spinal Cord Injury
United Kingdom
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2Recruiting
NCT07431281Phase 3Updated Sep 9, 2026
Sponsor: AstraZeneca
Gastric Cancer · Gastroesophageal Junction Adenocarcinoma · Esophageal Cancer
United States, Australia, Austria, Belgium, Brazil +19 more
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)Recruiting
NCT07463183Phase 2Updated Sep 9, 2026
Sponsor: Merck Sharp & Dohme LLC
Colitis Ulcerative · Ulcerative Colitis
United States, Canada, Colombia, France, Greece +4 more
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)Recruiting
NCT06716606Phase 3Updated Sep 9, 2026
Sponsor: GlaxoSmithKline
Connective Tissue Diseases
United States, Argentina, Australia, China, France +6 more
Continuous Heart Rate Variability Monitoring in Doctors; Understanding Patterns of Stress and Recovery and Their Relationship With Self-reported Resilience, Burnout and Wellbeing.Completed
NCT06721312N/AUpdated Sep 9, 2026
Sponsor: University of Aberdeen
Burnout · Burnout Syndrome · Occupational Stress · Stress
United Kingdom
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With InhibitorsActive Not Recruiting
NCT04083781Phase 3Updated Sep 9, 2026
Sponsor: Novo Nordisk A/S
Haemophilia A With Inhibitors · Haemophilia B With Inhibitors
United States, Algeria, Australia, Austria, Bulgaria +24 more
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseRecruiting
NCT07082738Phase 2Updated Sep 9, 2026
Sponsor: AstraZeneca
Chronic Obstructive Pulmonary Disease (COPD)
United States, Argentina, Australia, Bulgaria, Canada +19 more
A Long-Term Safety Study of PTC923 in Participants With PhenylketonuriaCompleted
NCT05166161Phase 3Updated Sep 9, 2026
Sponsor: PTC Therapeutics
Phenylketonuria
United States, Australia, Brazil, Canada, Czechia +14 more
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)Active Not Recruiting
NCT07234942Phase 1Updated Sep 9, 2026
Sponsor: Hoffmann-La Roche
Alzheimer's Disease
Canada, Netherlands, Spain, Sweden, United Kingdom
Weight and Metabolic Management StudyNot Yet Recruiting
NCT07789223NAUpdated Sep 9, 2026
Sponsor: Elenzia
Overweight · Obesity · Weight Maintenance
United Kingdom
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy SubjectsCompleted
NCT05384262Phase 1Updated Sep 9, 2026
Sponsor: AstraZeneca
Dyslipidemia
United States, United Kingdom
The Feasibility of Electrical Impedance Tomography to Guide Non-invasive Respiratory Interventions in Chronic Respiratory DiseaseEnrolling By Invitation
NCT07810283N/AUpdated Sep 9, 2026
Sponsor: Royal Free Hospital NHS Foundation Trust
COPD · Non Invasive Ventilation (NIV) · Obesity · Neuromuscular Disability
United Kingdom
Anatomical Landmarks for Chest Wall Perforators Used for Partial Breast ReconstructionRecruiting
NCT07006662N/AUpdated Sep 9, 2026
Sponsor: University Hospitals of North Midlands NHS Trust
Breast Cancer Female
United Kingdom
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)Recruiting
NCT06997497Phase 3Updated Sep 9, 2026
Sponsor: Merck Sharp & Dohme LLC
Colon Adenocarcinoma · Rectal Adenocarcinoma
United States, Argentina, Australia, Brazil, Canada +24 more
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)Recruiting
NCT07190248Phase 3Updated Sep 9, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +25 more
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic MigraineRecruiting
NCT05711394Phase 3Updated Sep 9, 2026
Sponsor: AbbVie
Episodic Migraine
United States, Belgium, Canada, Denmark, France +11 more
A Long-term Observational Study Evaluating the Presentation and Management of Acute Respiratory Tract Infections in Primary Care Across EuropeRecruiting
NCT06282718N/AUpdated Sep 9, 2026
Sponsor: European Clinical Research Alliance for Infectious Diseases (ECRAID)
Acute Respiratory Tract Infection
Belgium, France, United Kingdom
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)Recruiting
NCT06651281Phase 3Updated Sep 9, 2026
Sponsor: Merck Sharp & Dohme LLC
Crohn Disease · Colitis, Ulcerative
United States, Czechia, France, Georgia, Hungary +2 more
Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United KingdomRecruiting
NCT05557695N/AUpdated Sep 9, 2026
Sponsor: AstraZeneca
Chronic Lymphocytic Leukemia, CLL
United Kingdom
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 DiabetesActive Not Recruiting
NCT03811561Phase 3Updated Sep 9, 2026
Sponsor: Novo Nordisk A/S
Diabetes Mellitus, Type 2
United States, Brazil, Bulgaria, Canada, Czechia +14 more
Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation TherapyRecruiting
NCT05976685NAUpdated Sep 9, 2026
Sponsor: Insel Gruppe AG, University Hospital Bern
Ischemic Stroke · Atrial Fibrillation
Belgium, Germany, New Zealand, Spain, Switzerland +1 more

Previous page Next page